Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

NCS Multistage Holdings (NCSM) Shares Outstanding (Diluted Average) (2023 - 2026)

NCS Multistage Holdings has reported Shares Outstanding (Diluted Average) over the past 4 years, most recently at $2.6 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) fell 2.12% year-over-year to $2.6 million; the TTM value through Mar 2026 reached $2.6 million, down 2.12%, while the annual FY2025 figure was $2.7 million, 6.02% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 was $2.6 million at NCS Multistage Holdings, down from $2.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $2.7 million in Q4 2025 and troughed at $2.5 million in Q1 2023.
  • A 4-year average of $2.6 million and a median of $2.6 million in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 7.3% in 2025 and later fell 2.12% in 2026.
  • Year by year, Shares Outstanding (Diluted Average) stood at $2.5 million in 2023, then increased by 4.73% to $2.6 million in 2024, then rose by 6.02% to $2.7 million in 2025, then decreased by 4.26% to $2.6 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for NCSM at $2.6 million in Q1 2026, $2.7 million in Q4 2025, and $2.7 million in Q3 2025.